In postmenopausal women who were using combined estrogen - progestin therapy ( EPT ) at cohort enrollment , the OR of breast cancer was 2.31 ( 95 % CI = 1.47-3 .62 ) per minor allele of rs4149013 in SLCO1B1 ( P = 0.0003 ; within-gene PACT = 0.002 ; overall PACT = 0.023 ) .